Atheroembolic renal disease (cholesterol emboli)
Renal · Renal / Electrolyte
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Showering of cholesterol crystals from aortic plaques (after angiography, vascular surgery or anticoagulation) causing subacute AKI with skin and systemic features.
Red flags
- Progressive AKI
- Systemic embolisation (gut/limb ischaemia)
- Severe hypertension
- Multiorgan involvement
Assessment
Differential diagnosis
- Contrast-induced nephropathy
- Ischaemic ATN
- Vasculitis
- Interstitial nephritis
- Renal artery stenosis progression
Investigations
- U&E, FBC (eosinophilia), CRP, complement (may be low)
- Urinalysis, eosinophiluria
- Skin exam (livedo reticularis, blue toes)
- Fundoscopy (Hollenhorst plaques); biopsy (cholesterol clefts) if needed
Management
- Recognise subacute AKI days to weeks after a vascular procedure
- Supportive renal care and control blood pressure
- Statin therapy and cardiovascular risk management
- Avoid further arterial instrumentation and anticoagulation where possible
- Treat complications; renal replacement therapy if required
- Manage systemic and skin manifestations
Drugs & doses
Statin
Supportive care and BP control
Avoid/limit anticoagulation where feasible
RRT if needed
Disposition
Admit; nephrology and vascular input.
Complications & pitfalls
- Progressive/permanent renal impairment
- Limb and visceral ischaemia
- Recurrent embolisation
Exam pearls
- Look for the triad of a precipitating event, AKI and peripheral emboli (blue toes/livedo)
- Transient eosinophilia and low complement can occur
- Contrast may be an innocent bystander - consider atheroemboli in delayed AKI
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.